CRISPR new study, BIO, Eli Lilly retatrutide: Readout Newsletter

Hey, the date right now’s 6-26-26. Enjoyable.

Additionally, we’ve obtained additional advances in embryo enhancing, Sen. Invoice Cassidy is unveiling a invoice to wrestle with 340B drug reductions, and we assessment the vibes we picked up this 12 months at BIO. 

Embryo enhancing advances reignite moral debates

Scientists have used a more recent, extra exact type of CRISPR in early human embryos to raised perceive the genes at play throughout the earliest levels of human growth. The work, revealed in Nature, additionally suggests base enhancing is gentler than earlier variations of CRISPR, avoiding the chromosome injury that has raised security considerations. Nonetheless, the embryos ceaselessly ended up as mosaics, STAT’s Andrew Joseph and Megan Molteni write, with a mixture of edited and unedited cells.